Tag Archives: The Woolcock Institute of Medical Research

Asthma treatment option for PBS reimbursement

Since August 1, new once-daily asthma treatment option Arnuity Ellipta is being reimbursed on the PBS, according to GSK Australia. The listing provides “affordable access to another treatment option for suitable asthma patients aged 12 years and over”. “This new once-daily inhaler adds to the treatment options available to patients, …

Read More »